Quantcast

Pentec Health Announces Issuance of Hong Kong Patent for Renal Nutritional Supplement PROPLETE®

June 18, 2013

Patent expands company’s global reach.

Philadelphia, PA (PRWEB) June 18, 2013

Pentec Health today announced that it has received a Hong Kong patent for PROPLETE®, its proprietary Intradialytic Parenteral Nutrition (IDPN) supplement for patients suffering from Chronic Kidney Disease. The issuance of this patent expands the company´s international presence, aligning with its strategy for expanded growth around the globe. Earlier this year, Pentec announced a similar patent for the United Kingdom.

In addition, Pentec is actively pursuing patents for PROPLETE in several others countries. PROPLETE® is currently available in the United States through Pentec´s compounding pharmacy as a compounded drug.

According to the 2012 Hong Kong Renal Registry, there are approximately 8,197 patients receiving dialysis in Hong Kong; 15 percent, or 1,230, of whom are on hemodialysis.

“We are excited that the Hong Kong patent provides us with the opportunity to offer patients unique therapies specifically tailored to meet their nutritional needs. The expanded availability of PROPLETE can change the way IDPN is viewed and administered by nephrologists around the globe,” says Joseph Cosgrove, Pentec´s Chairman, President and CEO.

About Pentec Health, Inc.

Pentec Health Inc., celebrating its 30th year in business, is a privately held specialty infusion services and healthcare technology company headquartered in suburban Philadelphia. Cutting edge innovations in patient care allow Pentec Health to provide products and services to underserved patient populations. The Joint Commission has consistently awarded Pentec with a Gold Seal of Approval for their commitment to providing the highest level of patient safety and patient care for renal nutritional and specialty infusion home care services. Pentec’s renal nutrition business specializes in providing patient-specific, proprietary nutritional therapies for patients suffering from chronic kidney disease. Pentec’s specialty infusion business provides in-home care for patients with implanted drug delivery pumps treating severe pain and/or spasticity. Pentec’s award-winning executives are noted for top leadership and giving back to the communities in which they serve. For more information, visit http://www.pentechealth.com

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2013/6/prweb10842466.htm


Source: prweb



comments powered by Disqus